Department of Chemistry and Biochemistry, University of Arizona, 1306 East University Blvd, Tucson, AZ 85721, USA.
Curr Opin Chem Biol. 2011 Dec;15(6):789-97. doi: 10.1016/j.cbpa.2011.10.014. Epub 2011 Nov 7.
It has been estimated that 650,000 protein-protein interactions exist in the human interactome (Stumpf et al., 2008), a subset of all possible macromolecular partnerships that dictate life. Thus there is a continued need for the development of sensitive and user-friendly methods for cataloguing biomacromolecules in complex environments and for detecting their interactions, modifications, and cellular location. Such methods also allow for establishing differences in the interactome between a normal and diseased cellular state and for quantifying the outcome of therapeutic intervention. A promising approach for deconvoluting the role of macromolecular partnerships is split-protein reassembly, also called protein fragment complementation. This approach relies on the appropriate fragmentation of protein reporters, such as the green fluorescent protein or firefly luciferase, which when attached to possible interacting partners can reassemble and regain function, thereby confirming the partnership. Split-protein methods have been effectively utilized for detecting protein-protein interactions in cell-free systems, Escherichia coli, yeast, mammalian cells, plants, and live animals. Herein, we present recent advances in engineering split-protein systems that allow for the rapid detection of ternary protein complexes, small molecule inhibitors, as well as a variety of macromolecules including nucleic acids, poly(ADP) ribose, and iron sulfur clusters. We also present advances that combine split-protein systems with chemical inducers of dimerization strategies that allow for regulating the activity of orthogonal split-proteases as well as aid in identifying enzyme inhibitors. Finally, we discuss autoinhibition strategies leading to turn-on sensors as well as future directions in split-protein methodology including possible therapeutic approaches.
据估计,人类相互作用组(Stumpf 等人,2008)中存在 650,000 个蛋白质-蛋白质相互作用,这是决定生命的所有可能大分子相互作用的一个子集。因此,人们仍然需要开发敏感且易于使用的方法来对复杂环境中的生物大分子进行编目,并检测它们的相互作用、修饰和细胞位置。这些方法还允许确定正常和患病细胞状态之间相互作用组的差异,并量化治疗干预的结果。一种有前途的解析大分子相互作用作用的方法是分裂蛋白重组,也称为蛋白质片段互补。这种方法依赖于适当的蛋白质报告器的片段化,例如绿色荧光蛋白或萤火虫荧光素酶,当与可能的相互作用伙伴连接时,可以重新组装并恢复功能,从而确认伙伴关系。分裂蛋白方法已有效地用于检测无细胞系统、大肠杆菌、酵母、哺乳动物细胞、植物和活体动物中的蛋白质-蛋白质相互作用。在此,我们介绍了工程分裂蛋白系统的最新进展,这些系统允许快速检测三元蛋白质复合物、小分子抑制剂以及各种大分子,包括核酸、聚(ADP)核糖、铁硫簇。我们还介绍了将分裂蛋白系统与二聚化化学诱导物策略相结合的进展,这些策略允许调节正交分裂蛋白酶的活性,并有助于识别酶抑制剂。最后,我们讨论了导致开启传感器的自动抑制策略以及分裂蛋白方法学的未来方向,包括可能的治疗方法。